















National Reimbursement Category B
The telmisartan and amlodipine tablets are a compound formulation composed of telmisartan and amlodipine. Telmisartan is an angiotensin II receptor antagonist, and amlodipine is a dihydropyridine-type calcium channel blocker.
Primary Indications
Primary hypertension
Major Contraindications
• Known hypersensitivity to telmisartan, amlodipine, or any excipient of this product
• Hypersensitivity to dihydropyridine derivatives
• Second and third trimesters of pregnancy
• Breastfeeding period
• Obstructive biliary disorders
• Severe hepatic impairment
• Severe hypotension
• Shock (including cardiogenic shock)
• Left ventricular outflow tract obstruction (e.g., severe aortic stenosis)
• Hemodynamically unstable heart failure following acute myocardial infarction
• Concomitant use with aliskiren in patients with diabetes or renal impairment (GFR < 60 ml/min/1.73 m²)
Dosage Form
Tablets
Service Hotline:
Add:No. 66, Yong'an Road, High-tech Zone, Suzhou City, Jiangsu Province
Public Account
Service Number
Baijiahao
Copyright © 2025 Suzhou Chung-Hwa Chemical&Pharmaceutical Industrial Co.,Ltd. All Rights Reserved
Friendly Links: Chung-Hwa HoldingsSuzhou Chung-Hwa YuminChung-Hwa Lohas Health